Rossini D, Antoniotti C, Lonardi S, Pietrantonio F, et al. Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study b J Clin Oncol 2022 Jun 6:JCO2200839. doi: 10.1200/JCO.22.00839.
PMID: 35666229